课题基金 / 基金详情

SAFETY, EFFICACY, AND CELLULAR MECHANISMS OF 6 THIOGUANINE IN PSORIASIS

SAFETY, EFFICACY, AND CELLULAR MECHANISMS OF 6 THIOGUANINE IN PSORIASIS
6 硫鸟嘌呤治疗银屑病的安全性、有效性和细胞机制
批准号:
6115857
负责人:
JAMES G KRUEGER
金额:
$4.54万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-12-01 至 1999-11-30

项目摘要

项目成果

JAMES G KRUEGER的其他基金

相似基金

相关文献

中文摘要
翻译
我们正在研究细胞毒剂6-硫代鸟嘌呤治疗银屑病的机制,并通过血液动力学研究和直接皮肤组织研究来做到这一点。6-硫代鸟嘌呤是一种鸟嘌呤类似物,它被结合到细胞内的DNA中,取代正常的鸟嘌呤成分。这就阻止了细胞的复制。在年轻、快速生长的细胞群体中,这种药物的掺入比在老年群体中要大得多。在银屑病中使用这种药物是有意义的,因为银屑病是一种角质形成细胞快速增殖的疾病,也是一种伴有皮肤病变的淋巴细胞增殖的疾病。
英文摘要
We are studying the mechanism of the cytotoxic agent, 6-thioguanine, on psoriasis and are doing this through blood kinetic studies and direct skin tissue studies. 6-thioguanine is a guanine analog which is incorporated into the DNA in the cell in place of the normal guanine component. This prevents the cell from replicating. Incorporation of this agent is much greater in young, rapidly growing cell populations than in older populations. The use of this drug in psoriasis makes sense, as psoriasis is a disease of rapidly proliferating keratinocytes, as well as proliferating lymphocytes with skin lesions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHARMACODYNAMIC EFFECTS OF CYCLOSPORINE A IN MODERATE-SEVERE PSORIASIS
  • 批准号:
    7206998
  • 项目类别:
  • 资助金额:
    $0.03万
  • 财政年份:
    2005
  • 负责人:
    JAMES G KRUEGER
  • 依托单位:
SKIN BIOPSY FOR ANALYSIS OF CELL GROWTH, CELL DIFFERENTIATION AND INFLAMMATION
  • 批准号:
    7207013
  • 项目类别:
  • 资助金额:
    $0.03万
  • 财政年份:
    2005
  • 负责人:
    JAMES G KRUEGER
  • 依托单位:
NATURAL COURSE & HISTORY OF PSORIASIS BEFORE, DURING AND AFTER TREATMENT
  • 批准号:
    7207001
  • 项目类别:
  • 资助金额:
    $21.79万
  • 财政年份:
    2005
  • 负责人:
    JAMES G KRUEGER
  • 依托单位:
COLLECTION OF BLOOD SPECIMENS FOR RESEARCH PURPOSES
  • 批准号:
    7206995
  • 项目类别:
  • 资助金额:
    $2.94万
  • 财政年份:
    2005
  • 负责人:
    JAMES G KRUEGER
  • 依托单位:
海外基金